Dynamic Technology Lab Private Ltd Buys Shares of 27,207 Enhabit, Inc. (NYSE:EHAB)

Dynamic Technology Lab Private Ltd purchased a new position in Enhabit, Inc. (NYSE:EHAB) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 27,207 shares of the company’s stock, valued at approximately $215,000. Dynamic Technology Lab Private Ltd owned about 0.05% of Enhabit as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in EHAB. AREX Capital Management LP grew its holdings in shares of Enhabit by 2.5% in the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after buying an additional 59,353 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Enhabit by 1.5% during the second quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company’s stock worth $15,669,000 after purchasing an additional 26,753 shares during the period. Paradice Investment Management LLC increased its stake in Enhabit by 0.7% during the 2nd quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock worth $13,603,000 after purchasing an additional 11,128 shares in the last quarter. DekaBank Deutsche Girozentrale raised its holdings in Enhabit by 52.3% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock worth $4,306,000 after buying an additional 178,000 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Enhabit by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after purchasing an additional 5,936 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, Leerink Partners restated a “market perform” rating and issued a $8.00 price target (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to data from MarketBeat.com, Enhabit currently has an average rating of “Hold” and a consensus price target of $9.25.

Enhabit Trading Up 1.7 %

NYSE:EHAB opened at $7.86 on Tuesday. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $11.74. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm’s fifty day moving average is $7.45 and its 200-day moving average is $8.34. The firm has a market cap of $395.23 million, a P/E ratio of -3.39 and a beta of 1.84.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the prior year, the business earned $0.03 earnings per share. Equities analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.